Matthew Ringel
Chair, Department of Molecular Medicine and Therapeutics · Ohio State University Hospital
Credentials: · · ·
History
PresentDepartment of Molecular Medicine and Therapeutics · Ohio State University Hospital
- Present
Thyroid Cancer Unit · Ohio State University Hospital
- Present
Cancer Biology Program · Ohio State University Hospital
- 1987–1991
Research
Medullary thyroid cancer: management guidelines of the American Thyroid Association
Thyroid · 2009 · 912 citations
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
The Journal of Clinical Endocrinology & Metabolism · 2005 · 808 citations
Thyroid · 2025 · First of 20 authors · 499 citations
22 papers
17 papers
15 papers
14 papers
13 papers
11 papers
- LW
10 papers
- MT
10 papers
Grants
- 1997–2031
National Cancer Institute · P30
Project lead · $323.1K · Ohio State University
- 2020–2026
RCAN 1.4 Metastasis Suppressor in Thyroid Cancer
National Cancer Institute · R01
Contact PI · $2.2M · Ohio State University
- 2018–2024
Role of p21-Activated Kinases in Thyroid Cancer
National Cancer Institute · R01
Contact PI · $1.9M · Ohio State University
- 2018–2023
National Center for Advancing Translational Sciences · UL1
Contact PI · $4.6M · Ohio State University
Clinical trials
- 1998–2026
A Gene Hunting Study for Familial Papillary Thyroid Cancer
Principal investigator · Active not recruiting
Ohio State University Comprehensive Cancer Center